Autolus 2026 AGM passes all resolutions, re-elects directors and approves auditors

Autolus Therapeutics plc

Adopted 2025 annual accounts: 165,846,326 for, 2,895,344 against.
Directors' remuneration report approved: 156,192,216 for, 12,502,946 against.
Ernst & Young LLP (US) reappointed as auditors for the 2026-2027 fiscal year.
Directors M Bonney, E Leiderman, and RW Azelby re-elected with strong majorities.
All six resolutions passed on a poll at the 2026 Annual General Meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.